Bristol-Myers Squibb could pay a total of up to $444 million to acquire Galecto Biotech and its TD139 inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), plus potential milestones. The newly announced deal includes an option to acquire the company that must be exercised no later than 60 days after completion of a Phase 1b trial of … [Read more...] about BMS makes deal for inhaled galectin-3 inhibitor for idiopathic pulmonary fibrosis
News
Mystic Pharmaceuticals launches new intranasal delivery platform
Texas-based Mystic Pharmaceuticals has announced that its new Arrowfish intranasal delivery system is now available. The platform, which incorporates Mystic's VersiDoser and VRx2 blister systems, can deliver either liquid or dry powder formulations, in either mono- or multi-dose versions, and can be customized for use with a particular drug or biologic. Mystic CEO … [Read more...] about Mystic Pharmaceuticals launches new intranasal delivery platform
Discovery Labs announces personnel changes
Discovery Laboratories, which is developing Aerosurf aerosolized KL4 surfactant for the treatment of respiratory distress syndrome (RDS) in premature infants, has announced several management changes. Steven G. Simonson, who joined the company in May 2014, has been named Senior VP and Chief Development Officer and will oversee research, clinical and device … [Read more...] about Discovery Labs announces personnel changes
Additional Positive Phase 3 study results for AVP-825 intranasal sumatriptan
Avanir Pharmaceuticals has published results from the Phase 3 TARGET study of its AVP-825 intranasal sumatriptan powder compared to placebo for the treatment of migraine. The article appears in the January 2015 issue of Headache. Earlier this year, the company announced positive results from the Phase 3 COMPASS study that compared AVP-825 to oral … [Read more...] about Additional Positive Phase 3 study results for AVP-825 intranasal sumatriptan
Cirrus Pharmaceuticals to offer inhalation manufacturing services
North Carolina-based Cirrus Pharmaceuticals has announced that it will be investing in a new flexible cGMP suite at its facility in Research Triangle Park, NC and will offer new manufacturing services beginning next year. In July 2013, Cirrus announced that it had been acquired by Kemwell Biopharma. The company currently offers a number of analytical and development … [Read more...] about Cirrus Pharmaceuticals to offer inhalation manufacturing services
Irvine Pharmaceuticals opens facility in China
CDMO Irvine Pharmaceutical Services has announced that it will open a new 115,000 sq ft analytical facility in Hangzhou, China, the company said. The Hangzhou location should be fully operational in early 2015. While Irvine's California facilities offer a number of inhalation and intranasal product analytical testing services, the only OINDP-related service the … [Read more...] about Irvine Pharmaceuticals opens facility in China
CD-adapco introduces latest release of CFD software
Computer aided engineering softwared company CD-adapco has released STAR-CCM+ v9.06, with increased accuracy and faster set-up. The software is useful to inhaler and other device designers for realistic modeling of the behavior of aerosols in the device or drug deposition in the lungs. CD-adapco Senior VP of Product Management Jean-Claude Ercolanelli said, “We want … [Read more...] about CD-adapco introduces latest release of CFD software
Company launches crowd funding effort for DPI monitoring devices
A start-up company called Amiko has launched a campaign on crowd funding site Indiegogo to raise money for manufacturing of its monitoring devices for a variety of dry powder inhalers, the company said. The stated fundraising goal is $50,000. Although a press release says that the device is wearable, it is unclear from the company's marketing materials exactly how it … [Read more...] about Company launches crowd funding effort for DPI monitoring devices
Monaghan Medical presents data showing possible under-dosing from continuous nebulizers
US-based Monaghan Medical, which sells breath actuated nebulizers manufactured by Trudell Medical International (TMI), is presenting data at CHEST 2014 from a study showing that continuous nebulizers may under-dose medication. According to Monaghan changes in a patient's inspiratory/expiratory (I/E) ratio during tidal breathing can result in variable … [Read more...] about Monaghan Medical presents data showing possible under-dosing from continuous nebulizers
Apex Chromatography to be exclusive distributor for Copley Scientific products in India
Copley Scientific has announced a deal with Hyderabad-based Apex Chromatography for the exclusive distribution of Copley inhaler testing products in India and noted that Viraj Sohoni of Apex's Mumbai office has been appointed as the dedicated product manager for the Copley line. Representatives from Apex will also be available alongside Copley Scientific experts at … [Read more...] about Apex Chromatography to be exclusive distributor for Copley Scientific products in India